We count visits as totals without cookies, and never follow you from one day to the next. If you accept, we also use cookies to see how people use this site, so we can improve it. Privacy policy
Foreign stocks · NYSE · Healthcare · Medical supplies and devices
Held by 8 funds8 open to buy4 AMCs
Last close (USD)115.51+6.11 (+5.59%)as of 4 Nov 2026
Funds that hold it8One fund per scheme
Held through a master fund80 buy the stock themselves
Largest weight in a single fund17.53%Of that fund's NAV
Median weight2.88%Half the funds hold more than this
What does ABT do
Abbott Laboratories
Makes and sells a wide range of healthcare products, including medicines, diagnostic tests, medical devices and medical nutrition, with revenue spread across the world
FreeStyle LibreSimilacEnsureDisease diagnostic test kitsCardiac devices
Where the revenue comes from, and how much is left as profit (FY2025)
For every 100 dollars of sales: cost of sales 44 · operating expenses 38 · tax and other items 3 · leaving 15 as net profit
Which funds let you invest in ABT
Sorted by weight held, largest first
Investors in Thailand can buy ABT through 8 mutual funds open to retail investors. Most of them (8 funds) don't buy the stock themselves. Instead they invest in a master fund abroad, which in turn holds ABT.
The many funds holding less than 3% are usually index funds holding at market weight · Funds holding more than 8% have deliberately chosen a large position
How many funds each AMC holds it through
KASSET
How Thai money reaches ABT
4 master funds
Master fund
Thai funds using this route
Master fund's ABT weight
JPMorgan Funds – Global Healthcare Fund, Class A (acc) - USD
3
2.96%
JPMorgan Funds - Global Healthcare Fund
3
2.89%
iShares U.S. Medical Devices ETF
1
17.53%
State Street Health Care Select Sector SPDR ETF
1
2.75%
Data sourcesFunds that buy the stock themselves: top 5 holdings from the AMC's fact sheet as of 30 Sep 2026 · Funds that invest through a master fund: the master fund's portfolio from its issuer's fact sheet or prospectus · Each scheme counts as one fund · Share price: Market data · Financial statements: SEC EDGAR · Ratios: Market data · Revenue by business segment: SEC EDGAR · Weights are as of the report date, and funds can change their portfolios at any time · Investing involves risk. This is not investment advice.
K Global Healthcare Equity Fund
2.96%
Via JPMorgan Funds – Global Healthcare Fund, Class A (acc) - USD
Showing 8 of 8 funds you can buy · The full list is in the Expert view · Latest weights from portfolio reports, and funds can change their portfolios at any time · Past performance is not a guarantee of future performance
Valuation and key ratios
Abbott Laboratories · NYSE · Fiscal year ends in January
Market cap201.2B USD1.74 billion shares
P/E31.1xPrice ÷ FY2025 EPS 3.72
Forward P/E19.5xBased on forecast 12-month earnings
P/S4.2x
EV/EBITDA19.8x
Dividend yield2.18%2.52 USD per share a year
ROE13.1%Net profit ÷ shareholders' equity
Debt to equity (D/E)0.25xInterest-bearing debt
Beta0.50Against the S&P 500
Gross margin56.4%FY2025
Operating margin18.2%FY2025
Net margin14.7%FY2025
Price ratios use the latest close shown on this page · Forward P/E, P/S and EV/EBITDA from Market data · Beta from 5 years of monthly returns · Total dividends over the last 12 months
Company health made simple
From the FY2025 statements
Sales growth0.7%Slow growth
Yearly average over the last 4 years · Latest annual sales 44.3B USD
Profit from sales15%Moderate
For every 100 dollars of sales, about 15 dollars is left as net profit
Dividend2.18%Pays dividends
Per year, relative to the share price · Tech stocks tend to pay little because they reinvest their profits
1-year share price−8.2%Down
Now 11.5% below its 1-year high
A rise or fall in the share price doesn't move a fund by the same amount — a fund is affected only in proportion to how much it holds
Financial statements
Revenue grows 0.7% a year on average · EPS grows −1.4% a year on average
Annual · last 5 fiscal years
Revenue and net profit
FY202143.1B USD7.1B USD
FY202243.7B USD6.9B USD
FY202340.1B USD5.7B USD
FY202442.0B USD13.4B USD
FY202544.3B USD6.5B USD
Total revenue
Net profit
Quarterly · last 5 quarters
Revenue and net profit
Q1 FY202510.4B USD1.3B USD
Q2 FY202511.1B USD1.8B USD
Q3 FY202511.4B USD1.6B USD
Q4 FY202511.5B USD1.8B USD
Q1 FY202611.2B USD1.1B USD
Annual income statement, balance sheet and cash flow
Item (USD)
FY2021
FY2022
FY2023
FY2024
FY2025
Total revenue
43.1B USD
43.7B USD
40.1B USD
42.0B USD
44.3B USD
Gross profit
24.5B USD
24.5B USD
22.1B USD
23.2B USD
25.0B USD
Operating profit
Free cash flow = operating cash flow − capital expenditure · A cell showing N/A is an item the statement doesn't report, not a zero · Source: SEC EDGAR
Technical analysis
Closed at 115.51 USD on 4 Nov 2026
Daily trendClear uptrendScore 0.50 on a scale of −1 to +1 · 1253 bars
RSI(14)
73.5
ADX(14)
24.4
Position in the price range
94%
Weekly trendClear uptrendScore 0.90 on a scale of −1 to +1 · 261 bars
RSI(14)
62.4
ADX(14)
18.6
Position in the price range
69%
Monthly trendClear uptrendScore 0.50 on a scale of −1 to +1 · 61 bars
RSI(14)
51.8
ADX(14)
19.6
Position in the price range
57%
Moving averages (daily)
Period
SMA
EMA
Price vs line
10 days
106.27
107.50
Above
20 days
104.24
105.36
Above
50 days
104.05
104.04
Above
100 days
102.55
103.24
Above
200 days
Indicators (daily)
Indicator
Value
Signal
RSI(14)
73.50
Down
MACD(12,26)
2.02
Up
ADX(14)
24.39
Neutral
ATR(14) % of price
1.52
Neutral
Support and resistance (weekly pivots)
s3100
s2101
s1
Trend score = average of the moving-average group and the indicator group ((up signals − down signals) ÷ number of signals) · RSI and ATR use Wilder's method · MACD uses the 12- and 26-period EMA · An ADX of 25 or above counts as a clear trend · Calculated from daily closing prices from Market data · Not investment advice
One fund counted per scheme · Funds investing through a master fund show the master fund's weight in ABT, not the look-through weight · Past performance is not a guarantee of future performance
ONE-MEDTECHONE MEDICAL TECHNOLOGY FUND
K-GHEALTH
KFHHCARE-AKrungsri Global Healthcare Equity Hedged FX Fund
TUSHEALTH-ATISCO US Healthcare Fund